BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3439658)

  • 21. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety.
    Riley P; Maillard SM; Wedderburn LR; Woo P; Murray KJ; Pilkington CA
    Rheumatology (Oxford); 2004 Apr; 43(4):491-6. PubMed ID: 14722349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dermatomyositis in children].
    Dumas R
    Pediatrie; 1989; 44(2):83-6. PubMed ID: 2717339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.
    Huber AM; Lang B; LeBlanc CM; Birdi N; Bolaria RK; Malleson P; MacNeil I; Momy JA; Avery G; Feldman BM
    Arthritis Rheum; 2000 Mar; 43(3):541-9. PubMed ID: 10728746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatomyositis.
    Koler RA; Montemarano A
    Am Fam Physician; 2001 Nov; 64(9):1565-72. PubMed ID: 11730311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
    Adams EM; Pucino F; Yarboro C; Hicks JE; Thornton B; McGarvey C; Sonies BC; Bartlett ML; Villalba ML; Fleisher T; Plotz PH
    J Rheumatol; 1999 Feb; 26(2):352-60. PubMed ID: 9972969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of scleroderma and dermatomyositis in childhood].
    Ansell BM
    Clin Ter; 1978 Jan; 84(2):123-31. PubMed ID: 648095
    [No Abstract]   [Full Text] [Related]  

  • 27. [Juvenile dermatomyositis: 4 case studies].
    Marcil T; Khoudri I; Meziane M; Beqqal K; Khatibi I; Hassam B; Afifi Y; Benzekri L
    Arch Pediatr; 2008 Sep; 15(9):1443-5. PubMed ID: 18676126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatomyositis in the pediatric patient.
    Sullivan DB; Cassidy JT; Petty RE
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):327-31. PubMed ID: 263908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
    Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk factors in the development of idiopathic pulmonary hemosiderosis].
    Lapena S; Blanco A; Solís P; Linares P; Gómez S; Hernanz Sanz JL
    An Esp Pediatr; 1985 Jul; 23(1):5-11. PubMed ID: 4062075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two children with skin rash and muscle weakness: juvenile dermatomyositis].
    Boogaard R; Drexhage VR; van Suijlekom-Smit LW
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):146-50. PubMed ID: 15693592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis.
    McKendry RJ
    Arch Intern Med; 1987 Nov; 147(11):1989-91. PubMed ID: 3675101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the treatment of juvenile dermatomyositis.
    Stringer E; Feldman BM
    Curr Opin Rheumatol; 2006 Sep; 18(5):503-6. PubMed ID: 16896290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood dermatomyositis and polymyositis. Treatment with methotrexate and prednisone.
    Fischer TJ; Rachelefsky GS; Klein RB; Paulus HE; Stiehm ER
    Am J Dis Child; 1979 Apr; 133(4):386-9. PubMed ID: 433855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and outcome of pediatric Wegener's granulomatosis.
    Akikusa JD; Schneider R; Harvey EA; Hebert D; Thorner PS; Laxer RM; Silverman ED
    Arthritis Rheum; 2007 Jun; 57(5):837-44. PubMed ID: 17530684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscular strength as an index of response to therapy in childhood dermatomyositis.
    Resnick JS; Mammel M; Mundale MO; Kottke FJ
    Arch Phys Med Rehabil; 1981 Jan; 62(1):12-9. PubMed ID: 7458626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile dermatomyositis in north India.
    Singh S; Kumar L; Shankar KR
    Indian Pediatr; 1997 Mar; 34(3):193-8. PubMed ID: 9282485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases.
    Dinh HV; McCormack C; Hall S; Prince HM
    J Am Acad Dermatol; 2007 Jan; 56(1):148-53. PubMed ID: 17097377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Coexistence of hypothyroidism with polymyositis or dermatomyositis].
    Lukjanowicz M; Bobrowska-Snarska D; Brzosko M
    Ann Acad Med Stetin; 2006; 52 Suppl 2():49-55. PubMed ID: 17471837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.